MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$14,909,754
Loss before income
tax expense
-$14,865,712
Income tax expense
$44,042
Other income
$40,490
Health Care Patient
Service
$4,971,342
Histology Service Fees
$1,116,912
Medical Director Fees
$68,268
Other Revenues
$4,860
Department Of Defense
Observational Studies
$577
Interest income
$23,385
Loss from operations
-$10,572,508
Change in fair value of
warrants issued
$3,810,278
Other expense
$502,429
Net revenue
$6,161,959
Interest expense
$44,372
Total operating
expenses
$16,734,467
Selling, general and
administrative
$9,913,729
Direct costs and
expenses
$4,226,799
Research and development
$1,383,359
Clinical development
$705,744
Depreciation and
amortization
$504,836
Back
Back
Income Statement
source: myfinsight.com
bioAffinity Technologies, Inc. (BIAFW)
bioAffinity Technologies, Inc. (BIAFW)